Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul 17;189(28):E929-E939.
doi: 10.1503/cmaj.161390.

Nonnutritive sweeteners and cardiometabolic health: a systematic review and meta-analysis of randomized controlled trials and prospective cohort studies

Meghan B Azad  1 , Ahmed M Abou-Setta  2 , Bhupendrasinh F Chauhan  2 , Rasheda Rabbani  2 , Justin Lys  2 , Leslie Copstein  2 , Amrinder Mann  2 , Maya M Jeyaraman  2 , Ashleigh E Reid  2 , Michelle Fiander  2 , Dylan S MacKay  2 , Jon McGavock  2 , Brandy Wicklow  2 , Ryan Zarychanski  2
Affiliations
Review

Nonnutritive sweeteners and cardiometabolic health: a systematic review and meta-analysis of randomized controlled trials and prospective cohort studies

Meghan B Azad et al. CMAJ. .

Abstract

Background: Nonnutritive sweeteners, such as aspartame, sucralose and stevioside, are widely consumed, yet their long-term health impact is uncertain. We synthesized evidence from prospective studies to determine whether routine consumption of non-nutritive sweeteners was associated with long-term adverse cardiometabolic effects.

Methods: We searched MEDLINE, Embase and Cochrane Library (inception to January 2016) for randomized controlled trials (RCTs) that evaluated interventions for nonnutritive sweeteners and prospective cohort studies that reported on consumption of non-nutritive sweeteners among adults and adolescents. The primary outcome was body mass index (BMI). Secondary outcomes included weight, obesity and other cardiometabolic end points.

Results: From 11 774 citations, we included 7 trials (1003 participants; median follow-up 6 mo) and 30 cohort studies (405 907 participants; median follow-up 10 yr). In the included RCTs, nonnutritive sweeteners had no significant effect on BMI (mean difference -0.37 kg/m2; 95% confidence interval [CI] -1.10 to 0.36; I2 9%; 242 participants). In the included cohort studies, consumption of nonnutritive sweeteners was associated with a modest increase in BMI (mean correlation 0.05, 95% CI 0.03 to 0.06; I2 0%; 21 256 participants). Data from RCTs showed no consistent effects of nonnutritive sweeteners on other measures of body composition and reported no further secondary outcomes. In the cohort studies, consumption of nonnutritive sweeteners was associated with increases in weight and waist circumference, and higher incidence of obesity, hypertension, metabolic syndrome, type 2 diabetes and cardiovascular events. Publication bias was indicated for studies with diabetes as an outcome.

Interpretation: Evidence from RCTs does not clearly support the intended benefits of nonnutritive sweeteners for weight management, and observational data suggest that routine intake of nonnutritive sweeteners may be associated with increased BMI and cardiometabolic risk. Further research is needed to fully characterize the long-term risks and benefits of nonnutritive sweeteners. Protocol registration: PROSPERO-CRD42015019749.

PubMed Disclaimer

Conflict of interest statement

Competing interests: Jonthan McGavock has received speaker fees from Medtronic. No other competing interests were declared.

Figures

Figure 1:
Figure 1:
RISMA flow diagram. NNS = nonnutritive sweetener, RCT = randomized controlled trial. *Companion studies included abstracts, trial registrations and earlier reports from included studies.
Figure 2:
Figure 2:
Forest plots of consumption of NNS and selected cardiometabolic health outcomes. (A) Differences in mean BMI between NNS consumption and control groups for RCTs. A value less than 0 represents reduced BMI with NNS consumption. (B) Correlaton of BMI change per unit of NNS intake for cohort studies. A value less than 0 represents a reduced BMI. (C) Standard mean differences in weight between NNS consumption and control groups for RCTs. A value less than 0.0 represents weight loss. (D) Correlation of weight change per unit NNS intake for cohort studies. A value less than 0 favours weight loss. (E) Incidence of type 2 diabetes for highest versus lowest quantiles of NNS intake in cohort studies. A value less than 1.0 represents a lower risk of type 2 diabetes. Additional outcomes are shown in Table 3, and Appendix 1, Figures S1–4. Squares represent effect estimates within each study, with 95% CIs represented by horizontal lines. Square size is proportional to the weight of each study. Diamonds represent the weighted mean effect estimates. Cohort acronyms are defined in Table 2. Note: BMI = body mass index, CI = confidence interval, MD = mean difference, NNS = nonnutritive sweetener, RCT = randomized controlled trial, RR = risk ratio, SD = standard deviation, SE = standard error, SMD = standardized mean difference.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014;384:766–81. - PMC - PubMed
    1. Johnson RK, Appel LJ, Brands M, et al. Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. Circulation 2009;120:1011–20. - PubMed
    1. Siervo M, Montagnese C, Mathers JC, et al. Sugar consumption and global prevalence of obesity and hypertension: an ecological analysis. Public Health Nutr 2014;17:587–96. - PMC - PubMed
    1. Gardner C, Wylie-Rosett J, Gidding SS, et al. Nonnutritive sweeteners: current use and health perspectives: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 2012;35: 1798–808. - PMC - PubMed
    1. Sylvetsky AC, Welsh JA, Brown RJ, et al. Low-calorie sweetener consumption is increasing in the United States. Am J Clin Nutr 2012;96:640–6. - PMC - PubMed

Substances